Emily K. Bergsland

University of California, San Francisco — United States

Medicine · Health Sciences

55h-index17.6kcitations355works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroendocrine Tumor Research Advances(208), Neuroblastoma Research and Treatments(133), Lung Cancer Research Studies(123), Pancreatic and Hepatic Oncology Research(50), PI3K/AKT/mTOR signaling in cancer(31)

Publications355 total

Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy
Endocrine Pathology·2025· 1 cited
Flip Angle Optimization for Hepatobiliary Phase MRI at 0.55 T in Patients with Neuroendocrine Tumors
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202)
Journal of Clinical Oncology·2025· 1 citedOpen Access
1713P Efficacy of immune checkpoint inhibitors (ICI) in patients with advanced pancreatic NETs displaying high TMB and MMR alterations following treatment with alkylating agents
Annals of Oncology·2025
4D‐MRI at 0.55T for internal target volume delineation in liver radiation therapy planning
Medical Physics·2025Open Access
Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms
Annals of Surgical Oncology·2025· 1 cited
Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms
Cancer·2025· 1 cited
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
JCO Oncology Practice·2025· 6 cited
Appropriate use of tissue sampling and somatostatin receptor PET imaging in the diagnosis of pancreatic neuroendocrine tumors: results of an International Delphi Consensus
Surgical Endoscopy·2025· 1 citedOpen Access
Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors
Journal of the National Comprehensive Cancer Network·2025· 2 citedOpen Access
Flip Angle Optimization for Hepatobiliary Phase MRI at 0.55 T in Patients With Metastatic Neuroendocrine Tumors: A Prospective Study
American Journal of Roentgenology·2025· 1 cited
Supplementary Figure S2 from A Phase II Trial of the WEE1 Inhibitor Adavosertib in <i>SETD2</i><i>-</i>Altered Advanced Solid Tumor Malignancies (NCI 10170)
2025Open Access
Supplementary Protocol S1 from A Phase II Trial of the WEE1 Inhibitor Adavosertib in <i>SETD2</i><i>-</i>Altered Advanced Solid Tumor Malignancies (NCI 10170)
2025Open Access
Supplementary Table S4 from A Phase II Trial of the WEE1 Inhibitor Adavosertib in <i>SETD2</i><i>-</i>Altered Advanced Solid Tumor Malignancies (NCI 10170)
2025Open Access
Supplementary Figure S3 from A Phase II Trial of the WEE1 Inhibitor Adavosertib in <i>SETD2</i><i>-</i>Altered Advanced Solid Tumor Malignancies (NCI 10170)
2025Open Access
Characterization of early-onset gastroenteropancreatic neuroendocrine neoplasms at UCSF
Endocrine Abstracts·2025
Disparities in the rising incidence of early-onset neuroendocrine neoplasms
Endocrine Abstracts·2025
Liver-directed therapy for metastatic neuroendocrine carcinoma and grade 3 well-differentiated neuroendocrine tumors
Endocrine Abstracts·2025
Peptide receptor radionuclide therapy with 177 Lu-DOTATATE: a single center experience
Endocrine Abstracts·2025
Multicenter clinical registry of patients with a neuroendocrine tumor (NET) diagnosis receiving Lu-177-DOTATATE
Endocrine Abstracts·2025
page 1 of 18Next →

Frequent Co-authors

Jonathan Strosberg(14), Matthew H. Kulke(10), James C. Yao(10), Pamela L. Kunz(8), Alan P. Venook(8), Simron Singh(7), Manisha H. Shah(6), Þorvarður R. Hálfdánarson(6), Michael C. Soulen(6), Christopher H. Lieu(5), Jordan Berlin(5), James R. Howe(5), Rodney F. Pommier(5), Eric K. Nakakura(5), Andrew H. Ko(5), Margaret A. Tempero(5), Fairooz F. Kabbinavar(4), Herbert I. Hurwitz(4), Gabriele Bergers(4), Douglas Hanahan(4)